2021. Proportion of Subjects Achieving a Molluscum Lesion Count of 0 or 1 at the Day 84 End of Study Visit in Phase 3 Clinical Trials with VP-102 CAMP-1 and CAMP-2. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s92. DOI:https://doi.org/10.25251/skin.5.supp.92.